Mercator MedSystems
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
520 McCormick St, San Leandro, Californi...Website
www.mercatormed.comRevenue
$7.8 MillionIndustry
About Mercator MedSystems
Mercator MedSystems specializes in micro-infusion technology, particularly through their Bullfrog Micro-Infusion Device, which allows for targeted drug delivery in interventional angiographic settings. Their services focus on improving treatment outcomes for conditions such as Deep Vein Thrombosis (DVT) and below-the-knee restenosis. The company is actively involved in clinical trials, including the DEXTERITY trials, aimed at enhancing therapeutic efficacy and reducing chronic complications associated with DVT. Their intended clients include healthcare providers and institutions looking for advanced solutions in vascular therapy.Explore more
Mercator MedSystems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Mercator MedSystems
Compare insights from companies similar to Mercator MedSystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mercator MedSystems Tech Stack
A closer look at the technologies used by Mercator MedSystems
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mercator MedSystems
Sign Up For FreeTo access detailed company insights
Mercator MedSystems specializes in micro-infusion technology, particularly through their Bullfrog Micro-Infusion Device, which allows for targeted drug delivery in interventional angiographic settings. Their services focus on improving treatment outcomes for conditions such as Deep Vein Thrombosis (DVT) and below-the-knee restenosis. The company is... Read More
